Insider Selling: Surgery Partners, Inc. (NASDAQ:SGRY) Insider Sells 6,000 Shares of Stock

Surgery Partners, Inc. (NASDAQ:SGRYGet Free Report) insider Danielle Burkhalter sold 6,000 shares of the company’s stock in a transaction on Wednesday, June 12th. The stock was sold at an average price of $26.39, for a total transaction of $158,340.00. Following the transaction, the insider now directly owns 30,354 shares in the company, valued at $801,042.06. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Surgery Partners Price Performance

NASDAQ:SGRY opened at $25.00 on Friday. The firm has a market cap of $3.18 billion, a price-to-earnings ratio of 29.07, a price-to-earnings-growth ratio of 1.98 and a beta of 2.73. The company has a current ratio of 1.71, a quick ratio of 1.56 and a debt-to-equity ratio of 0.92. The company’s 50-day moving average is $25.72 and its two-hundred day moving average is $29.50. Surgery Partners, Inc. has a 12-month low of $22.05 and a 12-month high of $45.79.

Surgery Partners (NASDAQ:SGRYGet Free Report) last released its earnings results on Tuesday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02. The company had revenue of $717.40 million for the quarter, compared to analyst estimates of $707.66 million. Surgery Partners had a net margin of 0.02% and a return on equity of 3.65%. Research analysts expect that Surgery Partners, Inc. will post 0.88 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on SGRY shares. Barclays started coverage on shares of Surgery Partners in a research note on Wednesday, March 6th. They set an “equal weight” rating and a $35.00 price target on the stock. Citigroup decreased their price objective on shares of Surgery Partners from $42.00 to $38.00 and set a “buy” rating on the stock in a research report on Wednesday, May 8th. Royal Bank of Canada reiterated an “outperform” rating and issued a $49.00 price objective on shares of Surgery Partners in a research report on Thursday, February 29th. StockNews.com upgraded shares of Surgery Partners from a “sell” rating to a “hold” rating in a research report on Thursday, March 21st. Finally, Benchmark reiterated a “buy” rating and issued a $50.00 price objective on shares of Surgery Partners in a research report on Wednesday, May 1st. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $42.86.

Get Our Latest Report on Surgery Partners

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. DekaBank Deutsche Girozentrale purchased a new position in shares of Surgery Partners during the 3rd quarter worth about $39,000. Strs Ohio purchased a new position in shares of Surgery Partners during the 4th quarter worth about $51,000. Mesirow Institutional Investment Management Inc. lifted its holdings in shares of Surgery Partners by 12.4% during the 4th quarter. Mesirow Institutional Investment Management Inc. now owns 3,388 shares of the company’s stock worth $108,000 after acquiring an additional 373 shares during the period. Headlands Technologies LLC purchased a new position in shares of Surgery Partners during the 4th quarter worth about $145,000. Finally, EntryPoint Capital LLC lifted its holdings in shares of Surgery Partners by 257.1% during the 1st quarter. EntryPoint Capital LLC now owns 6,399 shares of the company’s stock worth $191,000 after acquiring an additional 4,607 shares during the period.

About Surgery Partners

(Get Free Report)

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

Featured Articles

Insider Buying and Selling by Quarter for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.